Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1741179 Target Snapshot

DNA dC->dU-editing enzyme APOBEC-3A · SINGLE PROTEIN · Homo sapiens

839Compounds
8Assays
1Approved Drugs
888.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P31941. Use UniProt P31941 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P31941 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats DNA dC->dU-editing enzyme APOBEC-3A as ChEMBL target CHEMBL1741179, mapped to UniProt P31941. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
DNA dC->dU-editing enzyme APOBEC-3A
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL1741179
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P31941
DNA dC->dU-editing enzyme APOBEC-3A
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether DNA dC->dU-editing enzyme APOBEC-3A is the right protein anchor across sources, using UniProt P31941 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelDNA dC->dU-editing enzyme APOBEC-3A
UniProt AccessionP31941
Component TypeProtein
Sequence Length199 aa

DNA dC->dU-editing enzyme APOBEC-3A

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as DNA dC->dU-editing enzyme APOBEC-3A, mapped to UniProt P31941. Sequence length is 199 aa.

Mapped IDP31941
Review nameDNA dC->dU-editing enzyme APOBEC-3A
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase III
1
Phase II
Assay Mix

Activity Type Distribution

IC50888.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1586607 6.05 IC50 892.0 Preclinical
CHEMBL1362702 5.97 IC50 1060.0 Preclinical
CHEMBL1503187 5.97 IC50 1070.0 Preclinical
CHEMBL589711 5.97 IC50 1080.0 Preclinical
CHEMBL3196851 5.94 IC50 1140.0 Preclinical
CHEMBL255881 5.92 IC50 1190.0 Preclinical
CHEMBL1338153 5.91 IC50 1240.0 Preclinical
CHEMBL1704847 5.9 IC50 1270.0 Preclinical
CHEMBL1577127 5.89 IC50 1300.0 Preclinical
CHEMBL1543727 5.88 IC50 1310.0 Preclinical
Distribution

pChEMBL Value Distribution

186
5.0
185
5.5
1
6.0
0
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

8
Total Assays
466
Tested Compounds
2
Assay Types
Functional — 4 assays, 466 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 4 466 5.3
Binding — 4 assays, 5 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 3 4 4.7
single protein format 1 1 5.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine